Flaegstad T, Gutteberg T, Kristiansen B E
Department of Pediatrics, University of Tromsø, Norway.
Scand J Infect Dis. 1990;22(5):547-51. doi: 10.3109/00365549009027094.
Sera from 33 children with and 84 without meningococcal disease were examined for antimeningococcal IgG and IgM antibodies using an ELISA test. The meningococcal patients had a significantly higher prevalence of specific IgG antibodies (p = 0.0014), and also higher prevalence of IgM antibodies (p = 0.08; NS) than other children. These results indicate that the patients had been immunologically stimulated for some time before admission. The meningococcal patients who died had lower prevalence of specific IgM antibodies than the surviving patients, but the difference was not significant (p = 0.16). A significant increase of or high level of antimeningococcal antibodies was found in 11/12 patients examined, the last one had high levels already at admission. This type of ELISA test should therefore be helpful in the diagnosis of meningococcal disease when blood or CSF cultures are negative.
采用酶联免疫吸附测定(ELISA)试验检测了33例患脑膜炎球菌病儿童和84例未患该病儿童的血清,以检测其抗脑膜炎球菌IgG和IgM抗体。脑膜炎球菌病患者特异性IgG抗体的患病率显著更高(p = 0.0014),IgM抗体的患病率也高于其他儿童(p = 0.08;无统计学意义)。这些结果表明,患者在入院前已受到免疫刺激一段时间。死亡的脑膜炎球菌病患者特异性IgM抗体的患病率低于存活患者,但差异无统计学意义(p = 0.16)。在12例接受检测的患者中,11例出现抗脑膜炎球菌抗体显著升高或处于高水平,最后1例在入院时即处于高水平。因此,当血液或脑脊液培养结果为阴性时,这种ELISA试验类型应有助于脑膜炎球菌病的诊断。